Hanson & Doremus Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $408K | Sell |
813
-60
| -7% | -$28.8K | 0.04% | 149 |
|
|
2026
Q1 | $429K | Sell |
873
-50
| -5% | -$27.1K | 0.05% | 135 |
|
|
2025
Q4 | $535K | Sell |
923
-13
| -1% | -$7.35K | 0.06% | 110 |
|
|
2025
Q3 | $454K | Buy |
936
+13
| +1% | +$6.05K | 0.06% | 122 |
|
|
2025
Q2 | $374K | Buy |
923
+60
| +7% | +$25.1K | 0.05% | 140 |
|
|
2025
Q1 | $429K | Sell |
863
-89
| -9% | -$48.2K | 0.06% | 125 |
|
|
2024
Q4 | $495K | Sell |
952
-84
| -8% | -$46.2K | 0.08% | 105 |
|
|
2024
Q3 | $641K | Hold |
1,036
| – | – | 0.1% | 95 |
|
|
2024
Q2 | $573K | Buy |
1,036
+155
| +18% | +$88.8K | 0.1% | 100 |
|
|
2024
Q1 | $512K | Sell |
881
-35
| -4% | -$19.6K | 0.09% | 111 |
|
|
2023
Q4 | $486K | Hold |
916
| – | – | 0.09% | 114 |
|
|
2023
Q3 | $464K | Buy |
916
+80
| +10% | +$42.6K | 0.1% | 113 |
|
|
2023
Q2 | $436K | Sell |
836
-37
| -4% | -$20K | 0.09% | 117 |
|
|
2023
Q1 | $503K | Hold |
873
| – | – | 0.11% | 108 |
|
|
2022
Q4 | $481K | Buy |
873
+18
| +2% | +$9.54K | 0.1% | 121 |
|
|
2022
Q3 | $434K | Sell |
855
-178
| -17% | -$99.6K | 0.11% | 113 |
|
|
2022
Q2 | $561K | Hold |
1,033
| – | – | 0.14% | 108 |
|
|
2022
Q1 | $610K | Buy |
1,033
+100
| +11% | +$57.4K | 0.13% | 109 |
|
|
2021
Q4 | $623K | Hold |
933
| – | – | 0.13% | 108 |
|
|
2021
Q3 | $533K | Buy |
933
+582
| +166% | +$319K | 0.12% | 110 |
|
|
2021
Q2 | $155K | Buy |
351
+13
| +4% | +$6.13K | 0.05% | 179 |
|
|
2021
Q1 | $154K | Hold |
338
| – | – | 0.04% | 201 |
|
|
2020
Q4 | $157K | Sell |
338
-13
| -4% | -$6.09K | 0.04% | 191 |
|
|
2020
Q3 | $155K | Hold |
351
| – | – | 0.05% | 179 |
|
|
2020
Q2 | $127K | Hold |
351
| – | – | 0.04% | 190 |
|
|
2020
Q1 | $100K | Hold |
351
| – | – | 0.03% | 206 |
|
|
2019
Q4 | $114K | Sell |
351
-29
| -8% | -$8.79K | 0.03% | 219 |
|
|
2019
Q3 | $111K | Hold |
380
| – | – | 0.03% | 221 |
|
|
2019
Q2 | $112K | Hold |
380
| – | – | 0.04% | 222 |
|
|
2019
Q1 | $104K | Hold |
380
| – | – | 0.03% | 215 |
|
|
2018
Q4 | $85K | Hold |
380
| – | – | 0.03% | 222 |
|
|
2018
Q3 | $93K | Hold |
380
| – | – | 0.03% | 229 |
|
|
2018
Q2 | $62K | Buy |
380
+80
| +27% | +$17K | 0.02% | 269 |
|
|
2018
Q1 | $62K | Hold |
300
| – | – | 0.02% | 276 |
|
|
2017
Q4 | $57K | Buy |
+300
| New | +$57.5K | 0.02% | 285 |
|
Other funds holding TMO
Hanson & Doremus Investment Management's TMO Position: Q2 2026 in Review
Hanson & Doremus Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 6.9% in Q2 2026, selling an estimated $28.8K and leaving 813 shares worth $408K. The position accounts for 0.04% of the portfolio, ranked #149.
Hanson & Doremus Investment Management first reported a position in TMO in Q4 2017 and has held it in 35 quarters since. The position peaked at $641K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Hanson & Doremus Investment Management held 813 shares of Thermo Fisher Scientific worth $408K as of Q2 2026.
- Hanson & Doremus Investment Management sold 60 Thermo Fisher Scientific shares in Q2 2026, an estimated $28.8K.
- Thermo Fisher Scientific made up 0.04% of Hanson & Doremus Investment Management's portfolio in Q2 2026, its #149 holding.
- Hanson & Doremus Investment Management first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 35 quarters since.
- Hanson & Doremus Investment Management's Thermo Fisher Scientific position peaked at $641K in Q3 2024.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Hanson & Doremus Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.